As of March 2024 Portola Pharmaceuticals has a market cap of $1.41 Billion. This makes Portola Pharmaceuticals the world's 4669th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.41 B | 0% |
2021 | $1.41 B | -0% |
2020 | $1.41 B | -23.96% |
2019 | $1.86 B | 43.1% |
2018 | $1.30 B | -59.06% |
2017 | $3.17 B | 150.34% |
2016 | $1.26 B | -56.24% |
2015 | $2.89 B | 109.96% |
2014 | $1.38 B | 31.09% |
2013 | $1.05 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $381.20 B | 26,839.02% | ๐บ๐ธ USA |
Pfizer PFE | $157.13 B | 11,004.51% | ๐บ๐ธ USA |
Sanofi SNY | $124.08 B | 8,669.20% | ๐ซ๐ท France |
Biogen BIIB | $31.34 B | 2,115.04% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $109.66 B | 7,649.74% | ๐บ๐ธ USA |